Cardiac resynchronization therapy is an evolving adjunctive therapeutic modality for the management of symptomatic heart failure.
Supports adjunctive CRT in symptomatic HF; leaves open optimal selection and integration with newer therapies.
Heart failure is a clinical syndrome comprised of a number of symptoms and signs associated with congestion and/or hypoperfusion. Specific pharmacologic therapies have been developed to slow disease progression from early to more advanced stages. Once symptoms have developed, aggressive multimodality interventions are instituted to alleviate symptoms and improve clinical status and quality of life; especially in those patients that present symptoms. Recently, an evolving adjunctive therapeutic modality, that involves using implanted electrical devices: cardiac resynchronization with or without implantable cardioverter defibrillators (ICD). has been used for management.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: